EarningsQ2 2026 Earnings Report

Align Tech (ALGN) Q2 2026 Earnings Report

0 Followers

Previous Report: Q1 2026

MX:ALGN Q2 2026 EPS Results

Actual EPS$47.94

Consensus EPS$47.51

Beat/MissBeat by +$0.44

One Year Ago EPS$45.22

MX:ALGN Q2 2026 Revenue Results

Actual Revenue$19.18B

Expected Revenue$19.10B

Beat/MissBeat by +$76.87M

YoY Revenue Growth+4.32%

Earnings Announcement Details

QuarterQ2 2026

Date07/29/2026

TimeAfter Close

Conference CallWednesday, July 29, 2026

MX:ALGN Upcoming Earnings

Align Tech's next earnings date is estimated for October 28, 2026, based on past reporting schedules.

Q2 2026 Earnings Call Audio

MX:ALGN Q2 2026 Earnings Call

0:00 / 0:00

Q2 2026 Earnings Slide Deck

Q2 2026 Earnings Call Summary

Q2 2026

Earnings Call Date:Jul 29, 2026|

% Change Since:

Earnings Call Sentiment|Positive

The call presented multiple clear wins — record revenues, record Clear Aligner volumes, non-GAAP margin expansion, strong cash balance and aggressive buybacks, and robust scanner adoption and digital workflow usage. Offsetting these positives are notable near-term headwinds: a double-digit decline in Systems & Services revenue driven by a strategic shift to lower-priced scanner offerings and leases, elevated operating expenses and one-time charges that pressure GAAP margins, a material U.K. VAT liability (~$37.5M), and FX-related margin/EPS impacts. Management framed the scanner mix shift as intentional, emphasizing long-term platform growth even as it depresses near-term reported revenue and upfront profitability. Given the number and magnitude of substantive positive operational and financial metrics and management’s constructive long-term positioning despite identifiable near-term challenges, the overall tone of the call is cautiously optimistic.

Company Guidance

Align guided Q3 2026 revenue of $1.00–$1.02 billion, with Clear Aligner volume up mid‑single digits year‑over‑year and ASPs down sequentially (mix and FX driven), Systems & Services revenue down sequentially and year‑over‑year, Q3 GAAP gross margin 67.5%–68.5% (down ~3–4 pts) reflecting $20–30M of one‑time charges (accelerated depreciation, restructuring), Q3 non‑GAAP gross margin ~71%, Q3 GAAP operating margin 13.5%–15% (with $35–50M of one‑time charges) and Q3 non‑GAAP operating margin ~24%. For full‑year 2026, Align still expects revenue growth of ~3%–4% YoY, Clear Aligner volume ~+6% YoY, Clear Aligner ASPs flat to slightly down, Systems & Services revenue down ~6%–8% YoY, iTero shipments up double digits, GAAP gross margin ~70.2%–70.5% (including $30–40M of one‑time items) and non‑GAAP gross margin +~100 bps, GAAP operating margin ~15.1%–15.6% (including ~$90–100M of one‑time items) and non‑GAAP operating margin ~23% (≈+100 bps YoY), CapEx $125–150M, and an expanded share repurchase plan of $400–500M for 2026 (inclusive of the ~$133M expected through October); management also targets at least another ~100 bps of GAAP and non‑GAAP operating margin improvement in fiscal 2027 (preliminary, pending the strategic/operating review).

Record Revenue and Clear Aligner Volume

Total Q2 2026 revenue of $1,056.2M, up 4.3% year-over-year, driven by record Clear Aligner shipments of 692,000 cases (up 7.4% YoY).

Clear Aligner Revenue and ASP Improvement

Q2 Clear Aligner revenue $870.9M, up 8.2% YoY. Average selling price per case $1,260, up 0.8% YoY (+$10), supported by price increases, lower net deferrals and favorable FX.

Non-GAAP Margin Expansion

Q2 non-GAAP operating margin 22.9%, up 1.6 percentage points YoY (approximately +3.1 pts at constant currency). Q2 non-GAAP gross margin 72.3%, up 1.8 points YoY (≈+2.6 pts at constant currency).

Strong Scanner Adoption and Digital Workflow Usage

iTero placements to new doctors reached a record and increased double digits YoY; active scanner installed base grew ~11% YoY; more than 12.4M restorative, wellness and orthodontic scans during Q2, up 16% YoY.

exocad Growth and Product Innovation

exocad delivered double-digit YoY revenue growth; launched exocad ART and hosted Insights 2026 (850+ professionals, 44+ countries) strengthening restorative-orthodontic integration.

Strong Cash Position and Share Repurchases

Cash & equivalents $1,102.6M (up $201.4M YoY). Q2 repurchases ~393,400 shares for $67M; company increased 2026 repurchase intent to $400M–$500M and has $733.3M available under the $1B program.

Healthy Free Cash Flow and CapEx Discipline

Q2 operating cash flow $192.8M; Q2 free cash flow $157.1M after $35.7M capex. Full-year 2026 capex guide $125M–$150M.

Affirmative FY26 Outlook for Core Metrics

Reiterated full-year 2026 revenue growth guidance of +3% to +4% YoY; Clear Aligner volume growth expected ~+6% for 2026; iTero shipments expected up double digits for 2026.

MX:ALGN Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 28, 2026	2026 (Q3)	50.78 / -	47.399	―
Jul 29, 2026	2026 (Q2)	47.51 / 47.94	45.22	6.02% (+2.72)
Apr 29, 2026	2026 (Q1)	41.68 / 46.85	38.682	21.13% (+8.17)
Feb 04, 2026	2025 (Q4)	54.01 / 59.75	44.312	34.84% (+15.44)
Oct 29, 2025	2025 (Q3)	43.64 / 47.40	42.678	11.06% (+4.72)
Jul 30, 2025	2025 (Q2)	46.73 / 45.22	43.767	3.32% (+1.45)
Apr 30, 2025	2025 (Q1)	36.07 / 38.68	38.864	-0.47% (-0.18)
Feb 05, 2025	2024 (Q4)	44.46 / 44.31	43.949	0.83% (+0.36)
Oct 23, 2024	2024 (Q3)	42.02 / 42.68	38.864	9.81% (+3.81)
Jul 24, 2024	2024 (Q2)	42.42 / 43.77	40.317	8.56% (+3.45)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed